Evidence map›Paper›PMID 38675098›Full record

ArticlePharmaceutics2024

Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis.

María S Magi, Yanina de Lafuente, Eride Quarta, María C Palena, Perla Del R Ardiles, Paulina L Páez, Fabio Sonvico, Francesca Buttini, Alvaro F Jimenez-Kairuz

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Hyaluronic Acid and Its Synthases-Current Knowledge.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Biopolymeric Inhalable Dry Powders for Pulmonary Drug Delivery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

María S MagiDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (UNC), Córdoba X5000GYA, Argentina.
Yanina de LafuenteDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (UNC), Córdoba X5000GYA, Argentina.
Eride QuartaFood and Drug Department, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.ORCID 0000-0003-0215-2350
María C PalenaDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (UNC), Córdoba X5000GYA, Argentina.
Perla Del R ArdilesDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (UNC), Córdoba X5000GYA, Argentina.
Paulina L PáezDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (UNC), Córdoba X5000GYA, Argentina.ORCID 0000-0003-4836-4842
Fabio SonvicoFood and Drug Department, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.ORCID 0000-0001-7372-1456
Francesca ButtiniFood and Drug Department, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.ORCID 0000-0002-4472-4823
Alvaro F Jimenez-KairuzDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (UNC), Córdoba X5000GYA, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversity of Parma · IT

Funding

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2017-3005 and 2020-1782European Union Horizon 2020, RISE Marie Skłodowska-Curie grant agreement N° 101007804 (Micro4Nano)Universidad Nacional de Córdoba SECyT-UNC, Consolidar 1, 2018-2022, N°: 32720220400365CB
6 · The paper itself

Abstract

Polyelectrolyte-drug complexes are interesting alternatives to improve unfavorable drug properties. Vancomycin (VAN) is an antimicrobial used in the treatment of methicillin-resistant

Indexed as

cystic fibrosishyaluronic acidinhalable vancomycinpolyelectrolyte–drug complexpulmonary infection

Identifiers

PMID38675098
PMCPMC11054002
OpenAlexW4393096102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.